Showing results (231-240 of 301) with videos related to

Sort By:
Pageof 31
Haematologica|December 22, 2010
Subcutaneous injections of low-dose veltuzumab (humanized anti-CD20 antibody) are safe and active in patients with indolent non-Hodgkin's lymphomaGeorge O Negrea, Rebecca Elstrom, Steven L Allen, et al.
Molecular Imaging and Biology|July 26, 2014
Pretargeted immunoPET of prostate cancer with an anti-TROP-2 x anti-HSG bispecific antibody in mice with PC3 xenograftsCatharina M van Rij, Cathelijne Frielink, David M Goldenberg, et al.
Plos One|September 7, 2012
Evaluation of a novel hexavalent humanized anti-IGF-1R antibody and its bivalent parental IgG in diverse cancer cell linesChien-Hsing Chang, Yang Wang, Preeti Trisal, et al.
Cancer|March 6, 2002
Radioimmunotherapy of small-volume disease of metastatic colorectal cancerThomas M Behr, Torsten Liersch, Lutz Greiner-Bechert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 22, 2006
Survival improvement in patients with medullary thyroid carcinoma who undergo pretargeted anti-carcinoembryonic-antigen radioimmunotherapy: a collaborative study with the French Endocrine Tumor GroupJean-François Chatal, Loïc Campion, Françoise Kraeber-Bodéré, et al.
Haematologica|February 13, 2008
Evaluation of response to fractionated radioimmunotherapy with 90Y-epratuzumab in non-Hodgkin's lymphoma by 18F-fluorodeoxyglucose positron emission tomographyCaroline Bodet-Milin, Françoise Kraeber-Bodéré, Benoît Dupas, et al.
Cancer|October 21, 2016
Repeated adjuvant anti-CEA radioimmunotherapy after resection of colorectal liver metastases: Safety, feasibility, and long-term efficacy results of a prospective phase 2 studyCarsten-O Sahlmann, Kia Homayounfar, Martin Niessner, et al.
Blood|June 25, 2010
Milatuzumab immunoliposomes induce cell death in CLL by promoting accumulation of CD74 on the surface of B cellsErin Hertlein, Georgia Triantafillou, Ellen J Sass, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2005
Phase II trial of carcinoembryonic antigen radioimmunotherapy with 131I-labetuzumab after salvage resection of colorectal metastases in the liver: five-year safety and efficacy resultsTorsten Liersch, Johannes Meller, Bettina Kulle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2006
Bispecific antibody pretargeting of tumor neovasculature for improved systemic radiotherapy of solid tumorsDieter Moosmayer, Dietmar Berndorff, Chien-Hsing Chang, et al.
Pageof 31